AAAAAA

   
Results: 1-20 |
Results: 20
Does primary stent implantation increase late mortality after myocardial infarction?
Authors: Glaser, R Herrmann, HC
Citation: R. Glaser et Hc. Herrmann, Does primary stent implantation increase late mortality after myocardial infarction?, CATHET C IN, 54(3), 2001, pp. 333-334
IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?
Authors: Swierkosz, TA Valettas, N Herrmann, HC
Citation: Ta. Swierkosz et al., IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?, CATHET C IN, 52(4), 2001, pp. 433-434
Facilitated percutaneous coronary intervention: results from the SPEED trial
Authors: Herrmann, HC Li, RH Ohman, EM
Citation: Hc. Herrmann et al., Facilitated percutaneous coronary intervention: results from the SPEED trial, EUR H J SUP, 3(A), 2001, pp. A26-A34
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban andabciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Authors: Topol, EJ Moliterno, DJ Herrmann, HC Powers, ER Grines, CL Cohen, DJ Cohen, EA Bertrand, M Neumann, FJ Stone, GW DiBattiste, PM Demopoulos, L
Citation: Ej. Topol et al., Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban andabciximab, for the prevention of ischemic events with percutaneous coronary revascularization., N ENG J MED, 344(25), 2001, pp. 1888-1894
Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension
Authors: Mahoney, PD Loh, E Blitz, LR Herrmann, HC
Citation: Pd. Mahoney et al., Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension, AM J CARD, 87(2), 2001, pp. 188-192
Combination therapy with clopidogrel and aspirin after coronary stenting
Authors: Kolansky, DM Klugherz, BD Curran, SC Herrmann, HC Magness, K Wilensky, RL Hirshfeld, JW
Citation: Dm. Kolansky et al., Combination therapy with clopidogrel and aspirin after coronary stenting, CATHET C IN, 50(3), 2000, pp. 276-279
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial
Authors: Herrmann, HC Moliterno, DJ Ohman, EM Stebbins, AL Bode, C Betriu, A Forycki, F Miklin, JS Bachinsky, WB Lincoff, AM Califf, RM Topol, EJ
Citation: Hc. Herrmann et al., Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction - Results from the SPEED (GUSTO-4 pilot) trial, J AM COL C, 36(5), 2000, pp. 1489-1496
Hemodynamic effects and long-term outcome of percutaneous balloon valvuloplasty in patients with mitral stenosis and atrial fibrillation
Authors: Tarka, EA Blitz, LR Herrmann, HC
Citation: Ea. Tarka et al., Hemodynamic effects and long-term outcome of percutaneous balloon valvuloplasty in patients with mitral stenosis and atrial fibrillation, CLIN CARD, 23(9), 2000, pp. 673-677
Hemodynamic effects of sildenafil - Reply
Authors: Herrmann, HC
Citation: Hc. Herrmann, Hemodynamic effects of sildenafil - Reply, N ENG J MED, 343(13), 2000, pp. 968-968
Hemodynamic effects of sildenafil in men with severe coronary artery disease
Authors: Herrmann, HC Chang, G Klugherz, BD Mahoney, PD
Citation: Hc. Herrmann et al., Hemodynamic effects of sildenafil in men with severe coronary artery disease, N ENG J MED, 342(22), 2000, pp. 1622-1626
New approaches to revascularization in acute myocardial infarction and stroke - Introduction
Authors: Herrmann, HC
Citation: Hc. Herrmann, New approaches to revascularization in acute myocardial infarction and stroke - Introduction, AM J CARD, 85(8A), 2000, pp. 1C-1C
Triple therapy for acute myocardial infarction: Combining fibrinolysis, platelet IIb/IIIa inhibition, and percutaneous coronary intervention
Authors: Herrmann, HC
Citation: Hc. Herrmann, Triple therapy for acute myocardial infarction: Combining fibrinolysis, platelet IIb/IIIa inhibition, and percutaneous coronary intervention, AM J CARD, 85(8A), 2000, pp. 10C-16C
Predictors of clinical outcome following percutaneous intervention for in-stent restenosis
Authors: Klugherz, BD Meneveau, NF Kolansky, DM Herrmann, HC Schiele, F Matthai, WH Groh, WC Untereker, WJ Hirshfeld, JW Bassand, JPL Wilensky, RL
Citation: Bd. Klugherz et al., Predictors of clinical outcome following percutaneous intervention for in-stent restenosis, AM J CARD, 85(12), 2000, pp. 1427-1431
Facilitated percutaneous coronary intervention: A novel concept in expediting and improving acute myocardial infarction care
Authors: Li, RH Herrmann, HC
Citation: Rh. Li et Hc. Herrmann, Facilitated percutaneous coronary intervention: A novel concept in expediting and improving acute myocardial infarction care, AM HEART J, 140(6), 2000, pp. S125-S135
Adenosine and ischemic preconditioning
Authors: Liang, BT Swierkosz, TA Herrmann, HC Kimmel, S Jacobson, KA
Citation: Bt. Liang et al., Adenosine and ischemic preconditioning, CUR PHARM D, 5(12), 1999, pp. 1029-1041
Tirofiban - An overview of the phase III trials
Authors: Herrmann, HC
Citation: Hc. Herrmann, Tirofiban - An overview of the phase III trials, J INVAS CAR, 11, 1999, pp. 7C-13C
ACC/AHA guidelines for Coronary Artery Bypass Graft Surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 Guidelines on Coronary Artery Bypass Graft Surgery)
Authors: Eagle, KA Guyton, RA Davidoff, R Ewy, GA Fonger, S Gardner, TJ Gott, JP Herrmann, HC Marlow, RA Nugent, WC O'Connor, GT Orszulak, TA Rieselbach, RE Winters, WL Yusuf, S Gibbons, RJ Alpert, JS Eagle, KA Gardner, TJ Garson, A Gregoratos, G Russell, RO Smith, SC McEntee, CW Elma, MA Pigman, GC Starke, RD Taubert, KA
Citation: Ka. Eagle et al., ACC/AHA guidelines for Coronary Artery Bypass Graft Surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 Guidelines on Coronary Artery Bypass Graft Surgery), J AM COL C, 34(4), 1999, pp. 1262-1342
ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: Executive summary and recommendations - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
Authors: Eagle, KA Guyton, RA Davidoff, R Ewy, GA Fonger, J Gardner, TJ Gott, JP Herrmann, HC Marlow, RA Nugent, W O'Connor, GT Orszulak, TA Rieselbach, RE Winters, WL Yusuf, S Gibbons, RJ Alpert, JS Eagle, KA Gardner, TJ Garson, A Gregoratos, G Russell, RO Ryan, TJ Smit, SC
Citation: Ka. Eagle et al., ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: Executive summary and recommendations - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery), CIRCULATION, 100(13), 1999, pp. 1464-1480
Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty
Authors: Gimple, LW Herrmann, HC Winniford, M Mammen, E
Citation: Lw. Gimple et al., Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty, AM J CARD, 83(11), 1999, pp. 1524-1529
Mechanical prosthetic valve thrombosis: Case report and review of the literature
Authors: Klugherz, BD Herrmann, HC
Citation: Bd. Klugherz et Hc. Herrmann, Mechanical prosthetic valve thrombosis: Case report and review of the literature, J THROMB TH, 6(3), 1998, pp. 253-259
Risultati: 1-20 |